{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:06Z","timestamp":1792791426696,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ncrna.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:39:39Z","timestamp":1718869179000},"page":"1249-1256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of miRNA-146a, miRNA-34a, and pro-inflammatory cytokines as a potential early indicators for type 1 diabetes mellitus"],"prefix":"10.1016","volume":"9","author":[{"given":"Amal A.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamil M.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim T.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona A.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada Maher","family":"Thabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.","family":"azzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira Yones","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maysa I.","family":"farghly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Al Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5811-7592","authenticated-orcid":false,"given":"Samia S.","family":"Alkhalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Aly Mohamed","family":"Abouaggour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noheir Ashraf","family":"Ibrahem Fathy Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ali","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1203-0808","authenticated-orcid":false,"given":"Wael","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed O.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ncrna.2024.06.001_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib2","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1186\/s12889-020-09502-x","article-title":"Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Publ. Health"},{"issue":"11","key":"10.1016\/j.ncrna.2024.06.001_bib3","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: current understanding and challenges","volume":"44","author":"Leslie","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ncrna.2024.06.001_bib4","series-title":"StatPearls [Internet]","article-title":"Type 1 diabetes","author":"Lucier","year":"2024"},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib5","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2013-2795","article-title":"Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study","volume":"133","author":"Dabelea","year":"2014","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"10.1016\/j.ncrna.2024.06.001_bib6","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes: Standards of medical Care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ncrna.2024.06.001_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet. Med. : a journal of the British Diabetic Association"},{"issue":"6","key":"10.1016\/j.ncrna.2024.06.001_bib8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/db15-1058","article-title":"Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes","volume":"65","author":"McLaughlin","year":"2016","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ncrna.2024.06.001_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"issue":"22","key":"10.1016\/j.ncrna.2024.06.001_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212165","article-title":"Micro-RNA implications in type-1 diabetes mellitus: a review of literature","volume":"22","author":"Margaritis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-021-03142-4","article-title":"MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS","volume":"19","author":"Barutta","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ncrna.2024.06.001_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8406438","article-title":"Decreased serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181ain autoimmune diabetes: potential biomarkers for diagnosis and possible involvement in pathogenesis","volume":"2019","author":"Liu","year":"2019","journal-title":"International journal of endocrinology"},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib13","doi-asserted-by":"crossref","DOI":"10.4161\/isl.27754","article-title":"Altering \u03b2-cell number through stable alteration of miR-21 and miR-34a expression","volume":"6","author":"Backe","year":"2014","journal-title":"Islets"},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4274\/jcrpe.galenos.2020.2020.0134","article-title":"Association of exosomal miR-34a with markers of dyslipidemia and endothelial dysfunction in children and adolescents with T1DM","volume":"12","author":"Ibrahim","year":"2020","journal-title":"Journal of clinical research in pediatric endocrinology"},{"key":"10.1016\/j.ncrna.2024.06.001_bib15","first-page":"68","volume":"42","author":"Al-Taee","year":"2018"},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib59","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3390\/healthcare11040485","article-title":"Allelic discrimination of vitamin D receptor polymorphisms and risk of type 2 diabetes mellitus: a case-controlled study","volume":"11","author":"Mohammed","year":"2023","journal-title":"Healthcare"},{"issue":"7","key":"10.1016\/j.ncrna.2024.06.001_bib16","first-page":"4838","article-title":"Relationship between lipid profile, inflammatory and endothelial dysfunction biomarkers, and type 1 diabetes mellitus: a case-control study","volume":"14","author":"Alkaabi","year":"2022","journal-title":"Am. J. Tourism Res."},{"key":"10.1016\/j.ncrna.2024.06.001_bib17","first-page":"359","article-title":"Citocinas de resposta Th1 e Th2 e diabetes mellitus tipo 1","volume":"1","author":"Nunes","year":"2017","journal-title":"Th1 Th2 Response Cytokins Type"},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib18","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/biomedicines11041120","article-title":"The relationship between type 1 diabetes mellitus, TNF-\u03b1, and IL-10 gene expression","volume":"11","author":"Dos Santos Haber","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.ncrna.2024.06.001_bib19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1074-7613(00)80198-3","article-title":"The temporal importance of TNFalpha expression in the development of diabetes","volume":"12","author":"Green","year":"2000","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib20","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-2567.2007.02715.x","article-title":"Pathogenicity of T helper 2 T-cell clones from T-cell receptor transgenic non-obese diabetic mice is determined by tumour necrosis factor-alpha","volume":"123","author":"He","year":"2008","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.ncrna.2024.06.001_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033254","article-title":"The role of TNF-\u03b1 in mice with type 1- and 2- diabetes","volume":"7","author":"Koulmanda","year":"2012","journal-title":"PLoS One"},{"issue":"44","key":"10.1016\/j.ncrna.2024.06.001_bib22","doi-asserted-by":"crossref","first-page":"15995","DOI":"10.1073\/pnas.0508122102","article-title":"The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.ncrna.2024.06.001_bib23","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.4049\/jimmunol.166.12.7023","article-title":"A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis","volume":"166","author":"Christen","year":"2001","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.ncrna.2024.06.001_bib24","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176157","article-title":"The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Qiao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ncrna.2024.06.001_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2987901","article-title":"The association between depression and type 1 diabetes mellitus: inflammatory cytokines as ferrymen in between?","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.ncrna.2024.06.001_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12026-022-09355-z","article-title":"The role of cytokines and T-bet, GATA3, ROR-\u03b3t, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes","volume":"71","author":"Ozgur","year":"2023","journal-title":"Immunol. Res."},{"issue":"7","key":"10.1016\/j.ncrna.2024.06.001_bib28","first-page":"4838","article-title":"Relationship between lipid profile, inflammatory and endothelial dysfunction biomarkers, and type 1 diabetes mellitus: a case-control study","volume":"14","author":"Alkaabi","year":"2022","journal-title":"Am. J. Tourism Res."},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2796.2000.00705.x","article-title":"Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors","volume":"248","author":"Lechleitner","year":"2000","journal-title":"J. Intern. Med."},{"issue":"6","key":"10.1016\/j.ncrna.2024.06.001_bib30","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/dom.15032","article-title":"Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: insights from a prospective longitudinal cohort study","volume":"25","author":"Arnold","year":"2023","journal-title":"Diabetes Obes. Metabol."},{"issue":"2","key":"10.1016\/j.ncrna.2024.06.001_bib31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.gene.2012.11.062","article-title":"The lack of association between interleukin-6 gene -174 G\/C polymorphism and the risk of type 1 diabetes mellitus: a meta-analysis of 18,152 subjects","volume":"515","author":"Yin","year":"2013","journal-title":"Gene"},{"issue":"356","key":"10.1016\/j.ncrna.2024.06.001_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad9943","article-title":"Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression","volume":"8","author":"Hundhausen","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"7090","key":"10.1016\/j.ncrna.2024.06.001_bib33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ncrna.2024.06.001_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00592-010-0226-0","article-title":"Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study","volume":"48","author":"Kong","year":"2011","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2011.07.020","article-title":"miR-21, miR-210, miR-34a, and miR-146a\/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study","volume":"219","author":"Raitoharju","year":"2011","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib37","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2337\/db09-0881","article-title":"Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells","volume":"59","author":"Roggli","year":"2010","journal-title":"Diabetes"},{"issue":"22","key":"10.1016\/j.ncrna.2024.06.001_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212165","article-title":"Micro-RNA implications in type-1 diabetes mellitus: a review of literature","volume":"22","author":"Margaritis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2024.06.001_bib38","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/258695","article-title":"Downregulation of Bcl-2 expression by miR-34a mediates palmitate-induced Min6 cells apoptosis","volume":"2014","author":"Lin","year":"2014","journal-title":"J. Diabetes Res."},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.4274\/jcrpe.galenos.2020.2020.0134","article-title":"Association of exosomal miR-34a with markers of dyslipidemia and endothelial dysfunction in children and adolescents with T1DM","volume":"12","author":"Ibrahim","year":"2020","journal-title":"Journal of clinical research in pediatric endocrinology"},{"key":"10.1016\/j.ncrna.2024.06.001_bib42","series-title":"MicroRNA Expression Fingerprint in Serum of Type 1 Diabetic Patients","author":"Sebastiani","year":"2012"},{"key":"10.1016\/j.ncrna.2024.06.001_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/srep31479","article-title":"Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study","volume":"6","author":"Seyhan","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191067","article-title":"Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes","volume":"13","author":"\u00c5kerman","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib39","first-page":"67","article-title":"The effects of all trans retinoic acid, vitamin D3 and their combination on plasma levels of miRNA-125a-5p, miRNA-34a, and miRNA-126 in an experimental model of diabetes","volume":"12","author":"Sharifzadeh","year":"2022","journal-title":"Avicenna journal of phytomedicine"},{"key":"10.1016\/j.ncrna.2024.06.001_bib45","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/DMSO.S231321","article-title":"The circulating micro-RNAs (-122, -34a and -99a) as predictive biomarkers for non-alcoholic fatty liver diseases","volume":"12","author":"Hendy","year":"2019","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"key":"10.1016\/j.ncrna.2024.06.001_bib46","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ncrna.2024.06.001_bib47","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2147\/DMSO.S231321","article-title":"The circulating micro-RNAs (-122, -34a and -99a) as predictive biomarkers for non-alcoholic fatty liver diseases","volume":"12","author":"Hendy","year":"2019","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"issue":"4","key":"10.1016\/j.ncrna.2024.06.001_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153497","article-title":"Association of circulating serum miR-34a and miR-122 with dyslipidemia among patients with non-alcoholic fatty liver disease","volume":"11","author":"Salvoza","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ncrna.2024.06.001_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/CS20110563","article-title":"MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression","volume":"123","author":"Tabuchi","year":"2012","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.ncrna.2024.06.001_bib50","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/ATVBAHA.116.308321","article-title":"P66Shc-Induced MicroRNA-34a causes diabetic endothelial dysfunction by downregulating Sirtuin1","volume":"36","author":"Li","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.ncrna.2024.06.001_bib51","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.xphs.2017.04.002","article-title":"Role of miR-34a in TGF-\u03b21- and drug-induced epithelial-mesenchymal transition in alveolar type II epithelial cells","volume":"106","author":"Takano","year":"2017","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.ncrna.2024.06.001_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8406438","article-title":"Decreased serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181ain autoimmune diabetes: potential biomarkers for diagnosis and possible involvement in pathogenesis","volume":"2019","author":"Liu","year":"2019","journal-title":"International journal of endocrinology"},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib53","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-021-03142-4","article-title":"MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS","volume":"19","author":"Barutta","year":"2021","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ncrna.2024.06.001_bib54","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/1753-0407.12163","article-title":"Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients 1miR-146","volume":"7","author":"Yang","year":"2015","journal-title":"J. Diabetes"},{"issue":"3","key":"10.1016\/j.ncrna.2024.06.001_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbrc.2017.06.196","article-title":"Decreased expression of miR-150, miR146a and miR424 in type 1 diabetic patients: association with ongoing islet autoimmunity","volume":"498","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ncrna.2024.06.001_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cellimm.2009.10.012","article-title":"microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients","volume":"260","author":"Hezova","year":"2010","journal-title":"Cell. Immunol."},{"issue":"6","key":"10.1016\/j.ncrna.2024.06.001_bib57","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ncrna.2024.06.001_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12967-021-03142-4","article-title":"MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS","volume":"19","author":"Barutta","year":"2021","journal-title":"J. Transl. Med."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054024001008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054024001008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:57:04Z","timestamp":1734051424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054024001008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2468054024001008"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2024.06.001","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of miRNA-146a, miRNA-34a, and pro-inflammatory cytokines as a potential early indicators for type 1 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}